Filing Details

Accession Number:
0000899243-16-024114
Form Type:
4
Zero Holdings:
No
Publication Time:
2016-07-01 17:05:50
Reporting Period:
2016-06-29
Filing Date:
2016-07-01
Accepted Time:
2016-07-01 17:05:50
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1105533 Argos Therapeutics Inc ARGS Pharmaceutical Preparations (2834) 562110007
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1669166 B.v. Forargos C/O Forbion Capital Partners
Goomieer 2-35
1411 Dc Naarden P7
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2016-06-29 1,322,618 $0.00 2,204,363 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Common Stock Warrants (right to buy) Acquisiton 2016-06-29 991,964 $0.00 991,964 $5.35
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
991,964 2016-06-29 2021-06-29 No 4 P Direct
Footnotes
  1. The reported securities are included within Units purchased by the Reporting Person for $5.44375 per Unit. Each Unit consists of one share of common stock and one warrant to purchase 0.75 shares of common stock.